Monogram Technologies Inc. (MGRM)
NASDAQ: MGRM · Real-Time Price · USD
2.790
-0.200 (-6.69%)
At close: Mar 28, 2025, 4:00 PM
2.820
+0.030 (1.08%)
After-hours: Mar 28, 2025, 7:52 PM EDT

Company Description

Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants.

The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.

Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens.

The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024.

Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas.

Monogram Technologies Inc.
Monogram Technologies logo
Country United States
Founded 2016
Industry Medical Devices
Sector Healthcare
Employees 27
CEO Benjamin Sexson

Contact Details

Address:
3913 Todd Lane, Suite 307
Austin, Texas 78744
United States
Phone 512 399 2656
Website monogramtechnologies.com

Stock Details

Ticker Symbol MGRM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001769759
CUSIP Number 609786108
ISIN Number US6097861081
Employer ID 81-2349540
SIC Code 3841

Key Executives

Name Position
Benjamin Sexson C.F.A. Chairman of the Board, President and Chief Executive Officer
Dr. Douglas Unis Founder, Chief Medical Officer and Director
Noel Knape CPA, M.B.A. Chief Financial Officer
Dr. Kamran Shamaei Ph.D. Chief Technology Officer
Chris Tyson Executive Vice President - MZ North America

Latest SEC Filings

Date Type Title
Mar 17, 2025 8-K Current Report
Mar 13, 2025 8-K/A [Amend] Current report
Mar 12, 2025 10-K Annual Report
Mar 12, 2025 8-K Current Report
Feb 25, 2025 8-K Current Report
Dec 26, 2024 8-K Current Report
Dec 18, 2024 8-K Current Report
Dec 2, 2024 8-K Current Report
Nov 14, 2024 10-Q Quarterly Report
Nov 14, 2024 8-K Current Report